Analysis of Real Costs and INA-CBG of Hyperthyroidism in Hasanuddin University Hospital
Abstract
Hyperthyroid disease requires continuous treatment with not cheap medical
costs. For JKN participants, the cost of treating hyperthyroidism has been fully
covered by BPJS through the INA-CBG package. However, there is often a
mismatch between the INA-CBG package and the real hospital costs thus causing
losses for the hospital. This research is a comparative study with a hospital
perspective and the purpose of this study is analyze difference between direct
medical cost of hospitals and INA-CBG package for the treatment of JKN
outpatient hyperthyroidism patient in Hasanuddin University Hospital (RSUH)
Makassar using data from January 2017 to December 2018. Data collection was
carried out by retrospective observational and data analysis using statistical non-
parametric tests. The results showed that INA-CBG package cannot cover all
components of the costs of treating hyperthyroid disease. The laboratory cost has
a proportion of 83% of the total medical cost, which is an average of IDR
465.683,70 every patient. Meanwhile, the INA-CBG rate with code Q-5-44-0 only
covers medical expenses of IDR 185.500 every patient. The conclusion of this
study shows that there is a negative difference (-) between the real cost of the
hospital and the INA-CBG rate, which is IDR 34.406.900,00 and an average of IDR
373.988.04 every patient. The recommendation is related to adjustment of the
INA-CBG rate to cover the riil costs.
References
Leo S De, Lee SY, Braverman LE, Unit E, Sciences C. Hyperthyroidism. HHS Public Access Author. 2016;388(10047):906-918.
Kemenkes RI. Situasi dan Analisis Penyakit Tiroid. Jakarta: Pusat Data dan Informasi Kementerian Kesehatan RI; 2015.
Kemenkes RI. Riset Kesehatan Dasar (Riskesdes). Jakarta: Kementerian Kesehatan RI; 2013.
Yu W, Wu N, Li L, Wang J, OuYang H, Shen H. Side Effects of PTU and MMI in The Treatment of Hyperthyroidism: A systematic Review and Meta-Analysis. Endocrine Practice. 2020;26(2):207-217.
Dipiro JoT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacoteraphy, a Phatophysiologic Approach 9th Edition. New York: McGraw-Hill Education; 2015.
Caputo M, Pecere A, Sarro A, et al. Incidence and Prevalence of Hyperthyroidism: A Population-Based Study in The Piedmont Region, Italy. Endocrine. 2020;69(1):107-112.
Okosieme OE, Taylor PN, Dayan CM. Should Radioiodine Now Be First Line Treatment For Graves’ Disease?. Springer Sci Bus Media New York. 2020;13(3):1-7.
BPJS Kesehatan. Paduan Praktis Administrasi Klaim Fasilitas Kesehatan BPJS Kesehatan. Jakarta: Badan Penyelenggara aminan Sosial; 2018.
BPJS Kesehatan. Panduan Praktis Pelayanan Kesehatan BPJS Kesehatan. Jakarta: Badan Penyelenggara Jaminan Sosial; 2017.
Wulan S, Herman A, Direja S, Reflisiani D. Penghitungan Biaya Satuan pada Instalasi Rawat Jalan di Rumah Sakit X Jambi menggunakan Metode Step Down. Jurnal Ekonomi Kesehatan Indonesia. 2017;3(1):43-50.
RS Universitas Hasanuddin. Data Rekam Medis Kunjungan Pasien Rawat Jalan. Makassar; Rumah Sakit Universitas Hasanuddin; 2018.
Rahayuningrum IO, Tamtomo DG, Suryono A. Analisis Tarif Rumah Sakit Dibandingkan dengan Tarif Indonesian Case Based Groups Pada Pasien Rawat Inap Peserta Jaminan Kesehatan Nasional Di Rumah Sakit. Pros Semin Nas Int. 2017;1(1):214-223.
Sugiyono. Metode Penelitian Kombinasi (Mixed Methods). Bandung: Alfabeta; 2018.
Taylor PN, Albrecht D, Scholz A, et al. Global Epidemiology of Hyperthyroidism and Hypothyroidism. Nature Reviews Endocrino-logy. 2018;14(5):301-316.
Chiovato L, Magri F, Carle A. Hypothyroidism in Context : Where We’ve Been and Where We’re Going. Adv Ther. 2019;2019(36):47-58.
Bové KB, Watt T, Vogel A, et al. Anxiety and Depression Are More Prevalent in Patients with Graves’ Disease than in Patients with Nodular Goitre. European Thyroid Journal. 2014;3(3):173-178.
Juwita DA, Suhatri, Hestia R. Antityroid Drug Use Evaluation on Hyperthyroid Patients in Dr. M. Djamil Hospital Padang, Indonesia. Jurnal Sains Farmasi dan Klinis. 2018;5 (1):49-54.
Meng Z, Liu M, Zhang Q, et al. Gender and Age Impacts on The Association Between Thyroid Function and Metabolic Syndrome in Chinese. Medicine (United States). 2015;94(50):1-9.
Zhang J, Huang C, Meng Z, et al. Gender-Specific Differences on the Association of Hypertension with Subclinical Thyroid Dysfunction. International Journal Endocrinology. 2019;2019:1-9.
Samuels M. Hyperthyroidism in Aging. In: Thyroid Disease Manager; 2018.
Barbesino G. Thyroid Function Changes in The Elderly and Their Relationship to Cardiovascular Health: A Mini-Review. Gerontology. 2019;65(1):1-8.
Ngurah IG, Dwi G, Sudarsa IW. Faktor- Faktor Yang Mempengaruhi Kualitas Hidup Pasien Kanker Tiroid Berdiferensiasi Baik (DTC) Paska Tiroidektomi Total di Rumah Sakit Umum Pusat (RSUP) Sanglah, Denpasar. Intisari Sains Medis. 2019;10(1):197-204.
Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389.
Yunitawati D, Santi K. Psychological Counseling And Anxiety In Patients With Hyperthyroidism In Klinik Litbang GAKI Magelang. Media Gizi Mikro Indonesia. 2014;6(1):53-62.
Liu J, Fu J, Xu Y, Wang G. Antithyroid Drug Therapy for Graves’ Disease and Implications for Recurrence. International Journal of Endocrinology. treatment; 2017:1-8.
Kamsyakawuni A, Gernowo R, Sarwoko EA. Aplikasi Sistem Pakar untuk Diagnosa Penyakit Hipertiroid dengan Metode Inferensi Fuzzy Mamdani. Jurnal Sistem Informasi Bisnis. 2012;2(2): 58-66.
Burch HB, Cooper DS. Management of Graves Disease. Journal American Medical Association. 2016;314(23):2544-2554.
Klaver EI, Loon HCM Van, Stienstra R, et al. Thyroid Hormone Status and Health-Related Quality of Life in the LifeLines Cohort Study. Thyroid Journal. 2013;23(9):1066-1073.
Brown DC. Thyroid Hormones, Antithyroid Drugs [Chapter 37]. Clinical Pharmacology 11th Vol. 4 ed. Elsevier Ltd; 2018.
Tjay TH, Rahardja K. Obat-Obat Penting Khasiat, Penggunaan, dan Efek Samping Edisi Ke 7. Jakarta: Elex Media
Komputindo; 2015.
Iglesias P, Bajo MA, Selgas R, Díez JJ. Thyroid Dysfunction and Kidney Disease : An Update. Reviews in Endocrine and Metabolic Disor-ders. 2017;18:131-144.
Akmal A, Kung J. Expert Opinion on Drug Safety Propylthiouracil, and Related Hepatotoxicity. Journal Expert Opinion on Drug Safety. 2014;13(10):1397-1406.
Siddiqui MF, Anwer H, Batool Z, Hasnain S, Imtiaz M. Assessment of Carbimazole, Propylthiouracil & L-Thyroxine For Liver Markers in Thyroid Patients From Punjab, Pakistan. Journal of Applied Pharmacy. 2015;7(1):105-113.
Baladi IH, Rai AA, Ahmed SM. ECG Changes in Patients With Primary Hyperthyroidism. Pan African Medical Journal. 2018;30:1-5.
Authors
Copyright (c) 2020 by author
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Copyright encompasses rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms and any other similar reproductions, as well as translations. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, such as electronic, electrostatic and mechanical copies, photocopies, recordings, magnetic media, etc.
All articles published Open Access are free for everyone to read and download. Under the CC-BY-NC-SA license, authors retain ownership of the copyright for their article, but authors grant others permission to use the content of publications in Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin in whole or in part provided that the original work is properly cited. Users (redistributors) of Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin are required to cite the original source, including the author's names, Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin as the initial source of publication, year of publication, and volume number.
Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin is licensed under Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.
